← Back to Search

Behavioral Intervention

Tobacco Use Treatment for Smoking Cessation

N/A
Recruiting
Led By Abbey Masonbrink, MD, MPH
Research Sponsored by Children's Mercy Hospital Kansas City
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 month follow up
Awards & highlights

Study Summary

This trial aims to help young people quit vaping and smoking with a tailored, evidence-based program.

Who is the study for?
This trial is for young people aged between 14 and 21 who are in the hospital, have used e-cigarettes in the past month, and can speak/read English. It's not suitable for those too ill to participate, with severe cognitive impairments or psychiatric conditions.Check my eligibility
What is being tested?
The study aims to develop and test a program designed to help adolescents quit vaping and smoking while they're admitted in the hospital. The effectiveness of this new tobacco use treatment intervention will be evaluated.See study design
What are the potential side effects?
Since this trial involves behavioral interventions rather than medications, there may be minimal physical side effects. However, participants might experience stress or anxiety related to quitting nicotine.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 month follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 month follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Self-reported 30-day abstinence
Secondary outcome measures
Acceptability of intervention in pediatric inpatient hospital setting
Feasibility of intervention
Fidelity of intervention delivered by a health educator

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Participants will complete the baseline survey, receive a behavioral health intervention supported by computerized decision support, and take an exit survey
Group II: ControlActive Control1 Intervention
Participants will complete the baseline survey and receive an informational brochure

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,492 Previous Clinical Trials
2,622,912 Total Patients Enrolled
9 Trials studying Vaping
4,928 Patients Enrolled for Vaping
Children's Mercy Hospital Kansas CityLead Sponsor
248 Previous Clinical Trials
935,815 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,720 Previous Clinical Trials
7,494,302 Total Patients Enrolled
2 Trials studying Vaping
1,613 Patients Enrolled for Vaping

Media Library

E-cigarette & Tobacco Use Treatment Intervention (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05936099 — N/A
Vaping Research Study Groups: Control, Intervention
Vaping Clinical Trial 2023: E-cigarette & Tobacco Use Treatment Intervention Highlights & Side Effects. Trial Name: NCT05936099 — N/A
E-cigarette & Tobacco Use Treatment Intervention (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05936099 — N/A
~81 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top